AAAAAA
Results: 1-25/30
Authors:
Ostendorf, T
Kunter, U
Grone, HJ
Bahlmann, F
Kawachi, H
Shimizu, F
Koch, KM
Janjic, N
Floege, J
Citation: T. Ostendorf et al., Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis, J AM S NEPH, 12(5), 2001, pp. 909-918
Authors:
Morath, C
Dechow, C
Lehrke, I
Haxsen, V
Waldherr, R
Floege, J
Ritz, E
Wagner, J
Citation: C. Morath et al., Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis, J AM S NEPH, 12(11), 2001, pp. 2300-2309
Authors:
Floege, J
Schaffer, J
Kock, KM
Citation: J. Floege et al., Scintigraphic methods to detect beta 2-microglobulin associated amyloidosis (A beta 2-microglobulin amyloidosis), NEPH DIAL T, 16, 2001, pp. 12-16
Authors:
Kielstein, JT
Helmchen, U
Netzer, KO
Weber, M
Haller, H
Floege, J
Citation: Jt. Kielstein et al., Conversion of Goodpasture's syndrome into membranous glomerulonephritis, NEPH DIAL T, 16(10), 2001, pp. 2082-2085
Authors:
Ketteler, M
Koch, KM
Floege, J
Citation: M. Ketteler et al., Imaging techniques in the diagnosis of dialysis-related amyloidosis, SEMIN DIAL, 14(2), 2001, pp. 90-93
Authors:
Phillips, AO
Baboolal, K
Riley, S
Grone, H
Janssen, U
Steadman, R
Williams, J
Floege, J
Citation: Ao. Phillips et al., Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus, AM J KIDNEY, 37(2), 2001, pp. 400-410
Authors:
Frank, RD
Weber, J
Dresbach, H
Thelen, H
Weiss, C
Floege, J
Citation: Rd. Frank et al., Role of contact system activation in hemodialyzer-induced thrombogenicity, KIDNEY INT, 60(5), 2001, pp. 1972-1981
Authors:
Kurts, C
Klebba, I
Davey, GM
Koch, KM
Miller, JFAP
Heath, WR
Floege, J
Citation: C. Kurts et al., Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration, KIDNEY INT, 60(2), 2001, pp. 664-671
Authors:
Floege, J
Ketteler, M
Citation: J. Floege et M. Ketteler, beta(2)-microglobulin-derived amyloidosis: An update, KIDNEY INT, 59, 2001, pp. S164-S171
Authors:
Floege, J
Ostendorf, T
Citation: J. Floege et T. Ostendorf, Platelet-derived growth factor: A new clinical target on the horizon, KIDNEY INT, 59(4), 2001, pp. 1592-1593
Authors:
Mertens, PR
Floege, J
Citation: Pr. Mertens et J. Floege, Treatment of IgA nephritis: a critical viewpoint, DEUT MED WO, 125(34-35), 2000, pp. 1010-1010
Authors:
Wagner, J
Dechow, C
Morath, C
Lehrke, I
Amann, K
Waldherr, R
Floege, J
Ritz, E
Citation: J. Wagner et al., Retinoic acid reduces glomerular injury in a rat model of glomerular damage, J AM S NEPH, 11(8), 2000, pp. 1479-1487
Authors:
Joles, JA
Kunter, U
Janssen, U
Kriz, W
Rabelink, TJ
Koomans, HA
Floege, J
Citation: Ja. Joles et al., Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats, J AM S NEPH, 11(4), 2000, pp. 669-683
Authors:
Bokemeyer, D
Ostendorf, T
Kunter, U
Lindemann, M
Kramer, HJ
Floege, J
Citation: D. Bokemeyer et al., Differential activation of mitogen-activated protein kinases in experimental mesangioproliferative glomerulonephritis, J AM S NEPH, 11(2), 2000, pp. 232-240
Authors:
Floege, J
Feehally, J
Citation: J. Floege et J. Feehally, IgA nephropathy: Recent developments, J AM S NEPH, 11(12), 2000, pp. 2395-2403
Authors:
Lonnemann, G
Floege, J
Kliem, V
Brunkhorst, R
Koch, KM
Citation: G. Lonnemann et al., Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system, NEPH DIAL T, 15(8), 2000, pp. 1189-1193
Authors:
Janssen, U
Bahlmann, F
Kohl, J
Zwirner, J
Haubitz, M
Floege, J
Citation: U. Janssen et al., Activation of the acute phase response and complement C3 in patients with IgA nephropathy, AM J KIDNEY, 35(1), 2000, pp. 21-28
Authors:
Schaffer, J
Burchert, W
Floege, J
Gielow, P
Kionka, C
Linke, RP
Weiss, EH
Shaldon, S
Koch, KM
Citation: J. Schaffer et al., Recombinant versus natural human In-111-beta(2)-microglobulin for scintigraphic detection of A beta(2)m amyloid in dialysis patients, KIDNEY INT, 58(2), 2000, pp. 873-880
Authors:
Coimbra, TM
Janssen, U
Grone, HJ
Ostendorf, T
Kunter, U
Schmidt, H
Brabant, G
Floege, J
Citation: Tm. Coimbra et al., Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes, KIDNEY INT, 57(1), 2000, pp. 167-182
Authors:
Phillips, AO
Janssen, U
Floege, J
Citation: Ao. Phillips et al., Progression of diabetic nephropathy - Insights from cell culture studies and animal models, KIDNEY BL P, 22(1-2), 1999, pp. 81-97
Authors:
Janssen, U
Phillips, AO
Floege, J
Citation: U. Janssen et al., Rodent models of nephropathy associated with type II diabetes, J NEPHROL, 12(3), 1999, pp. 159-172
Authors:
Floege, J
Ostendorf, T
Janjic, N
Citation: J. Floege et al., Aptamers: Novel tools for specific intervention studies, NEPH DIAL T, 14(6), 1999, pp. 1354-1357
Authors:
Ostendorf, T
Floege, J
Citation: T. Ostendorf et J. Floege, Aptamers: a novel approach to intervention studies and the development of novel therapeutic approaches, MED KLIN, 94(4), 1999, pp. 219-223
Authors:
Floege, J
Burg, M
Al Masri, AN
Grone, HJ
von Wussow, P
Citation: J. Floege et al., Expression of interferon-inducible Mx-proteins in patients with IgA nephropathy or Henoch-Schonlein purpura, AM J KIDNEY, 33(3), 1999, pp. 434-440
Authors:
Floege, J
Hudkins, KL
Eitner, F
Cui, Y
Morrison, RS
Schelling, MA
Alpers, CE
Citation: J. Floege et al., Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney, KIDNEY INT, 56(3), 1999, pp. 883-897